Microbiology
Why do inactivated vaccines typically induce mainly humoral immune responses instead of strong cell-mediated (CD8+ T cell) responses?
What is the primary role of an adjuvant in an inactivated vaccine formulation?
A public health team must choose between distributing an attenuated vaccine that requires a reliable cold chain and an inactivated vaccine that is heat-stable. Which trade-off analysis is correct for a low-resource setting with many remote clinics?
